placeholder image
F Ismail-Beigi All authors
About
Publications
selected publications
Journal Article
  • Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. 
    JAMA cardiology. 2017
  • Insulin dose and cardiovascular mortality in the ACCORD Trial. 
    Diabetes care. 2015
  • Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. 
    Diabetologia. 2014
  • Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial. 
    Diabetes care. 2014
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. 
    Diabetes care. 2012
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes. 
    New England Journal of Medicine. 2011
  • Near-normalization of glucose and microvascular diabetes complications: data from ACCORD and ADVANCE. 
    Therapeutic Advances in Endocrinology and Metabolism. 2011
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • Effects of combination lipid therapy in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ quality & safety. 2010
  • Effects of intensive glucose lowering in type 2 diabetes. 
    New England Journal of Medicine. 2008
    • Abstract
  • Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. 
    Diabetologia. 2011
    • presentations
    Contact
    full name
  • F Ismail-Beigi
  • F. Ismail-Beigi
    • Quick Info
     
    Collaboration